Back to Search Start Over

A sphingosine 1-phosphate receptor 2 selective allosteric agonist.

Authors :
Satsu H
Schaeffer MT
Guerrero M
Saldana A
Eberhart C
Hodder P
Cayanan C
Schürer S
Bhhatarai B
Roberts E
Rosen H
Brown SJ
Source :
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2013 Sep 01; Vol. 21 (17), pp. 5373-82. Date of Electronic Publication: 2013 Jun 15.
Publication Year :
2013

Abstract

Molecular probe tool compounds for the Sphingosine 1-phosphate receptor 2 (S1PR2) are important for investigating the multiple biological processes in which the S1PR2 receptor has been implicated. Amongst these are NF-κB-mediated tumor cell survival and fibroblast chemotaxis to fibronectin. Here we report our efforts to identify selective chemical probes for S1PR2 and their characterization. We employed high throughput screening to identify two compounds which activate the S1PR2 receptor. SAR optimization led to compounds with high nanomolar potency. These compounds, XAX-162 and CYM-5520, are highly selective and do not activate other S1P receptors. Binding of CYM-5520 is not competitive with the antagonist JTE-013. Mutation of receptor residues responsible for binding to the zwitterionic headgroup of sphingosine 1-phosphate (S1P) abolishes S1P activation of the receptor, but not activation by CYM-5520. Competitive binding experiments with radiolabeled S1P demonstrate that CYM-5520 is an allosteric agonist and does not displace the native ligand. Computational modeling suggests that CYM-5520 binds lower in the orthosteric binding pocket, and that co-binding with S1P is energetically well tolerated. In summary, we have identified an allosteric S1PR2 selective agonist compound.<br /> (Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1464-3391
Volume :
21
Issue :
17
Database :
MEDLINE
Journal :
Bioorganic & medicinal chemistry
Publication Type :
Academic Journal
Accession number :
23849205
Full Text :
https://doi.org/10.1016/j.bmc.2013.06.012